Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-31,956
Closed -$1.03M 4743
2026
Q1
$1.03M Buy
31,956
+9,100
+40% +$337K 0.02% 1387
2025
Q4
$962K Buy
+22,856
New +$921K 0.03% 1052
2025
Q1
Sell
-21,223
Closed -$840K 3162
2024
Q4
$840K Sell
21,223
-26,970
-56% -$1.02M 0.07% 399
2024
Q3
$1.64M Buy
+48,193
New +$1.36M 0.12% 204
2023
Q4
Sell
-29,420
Closed -$657K 2188
2023
Q3
$657K Buy
29,420
+19,821
+206% +$510K 0.11% 245
2023
Q2
$244K Buy
+9,599
New +$233K 0.04% 864

Other funds holding VCYT

XTX Topco's VCYT Position: Q2 2026 in Review

XTX Topco sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 31,956 shares — an estimated $1.03M sold.

XTX Topco first reported a position in VCYT in Q2 2023 and held it in 6 quarters. The position peaked at $1.64M in Q3 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • XTX Topco reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 31,956 Veracyte shares in Q2 2026, an estimated $1.03M.
  • XTX Topco first reported a position in Veracyte in Q2 2023 and held it in 6 quarters.
  • XTX Topco's Veracyte position peaked at $1.64M in Q3 2024.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.